Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 148

1.

No increase in demyelinating diseases after hepatitis B vaccination.

Zipp F, Weil JG, Einhäupl KM.

Nat Med. 1999 Sep;5(9):964-5. No abstract available.

PMID:
10470051
2.

Central demyelinating disorders and hepatitis B vaccination: a risk-benefit approach for pre-adolescent vaccination in France.

Lévy-Bruhl D, Desenclos JC, Rebière I, Drucker J.

Vaccine. 2002 May 15;20(16):2065-71.

PMID:
11972975
3.

Hepatitis B vaccine and risk of relapse after a first childhood episode of CNS inflammatory demyelination.

Mikaeloff Y, Caridade G, Assi S, Tardieu M, Suissa S; KIDSEP study group of the French Neuropaediatric Society..

Brain. 2007 Apr;130(Pt 4):1105-10.

PMID:
17276994
4.

[Pharmacovigilance of hepatitis B vaccines].

Imbs JL, Decker N, Welsch M.

Bull Acad Natl Med. 2003;187(8):1489-98; discussion 1498-500. French.

PMID:
15146580
5.

Hepatitis B vaccination and multiple sclerosis: evidence from a systematic review.

Demicheli V, Rivetti A, Di Pietrantonj C, Clements CJ, Jefferson T.

J Viral Hepat. 2003 Sep;10(5):343-4. Review. No abstract available.

PMID:
12969184
6.

[Central nervous system demyelinating events and hepatitis B vaccine: a new episode of the never ending French saga!].

Costagliola D.

Rev Epidemiol Sante Publique. 2008 Dec;56(6):379-81. doi: 10.1016/j.respe.2008.10.006. French. No abstract available.

PMID:
19019601
7.

Hepatitis B vaccination and first central nervous system demyelinating events: reanalysis of a case-control study using the self-controlled case series method.

Hocine MN, Farrington CP, Touzé E, Whitaker HJ, Fourrier A, Moreau T, Tubert-Bitter P.

Vaccine. 2007 Aug 1;25(31):5938-43.

PMID:
17597263
8.

A population-based, postlicensure evaluation of the safety of a combination diphtheria, tetanus, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine in a large managed care organization.

Zangwill KM, Eriksen E, Lee M, Lee J, Marcy SM, Friedland LR, Weston W, Howe B, Ward JI.

Pediatrics. 2008 Dec;122(6):e1179-85. doi: 10.1542/peds.2008-1977.

PMID:
19047220
9.

[Hepatitis B vaccination: a review].

Launay O, Floret D.

Med Sci (Paris). 2015 May;31(5):551-8. doi: 10.1051/medsci/20153105018. Review. French. No abstract available.

10.

Hepatitis B vaccination and first central nervous system demyelinating event: a case-control study.

Touzé E, Fourrier A, Rue-Fenouche C, Rondé-Oustau V, Jeantaud I, Bégaud B, Alpérovitch A.

Neuroepidemiology. 2002 Jul-Aug;21(4):180-6.

PMID:
12065880
11.

Multiple sclerosis and vaccination against hepatitis B: analysis of risk benefit profile.

Tosti ME, Traversa G, Bianco E, Mele A.

Ital J Gastroenterol Hepatol. 1999 Jun-Jul;31(5):388-91.

PMID:
10470598
12.

Continue to vaccinate against hepatitis B.

[No authors listed]

Prescrire Int. 2009 Jun;18(101):131.

PMID:
19637437
13.

Hepatitis B vaccine and the risk of CNS inflammatory demyelination in childhood.

Mikaeloff Y, Caridade G, Suissa S, Tardieu M.

Neurology. 2009 Mar 10;72(10):873-80. doi: 10.1212/01.wnl.0000335762.42177.07.

PMID:
18843097
14.
15.

Hepatitis B vaccines (continued): risks of systemic adverse reactions to hepatitis B vaccines appear to be very rare.

[No authors listed]

Prescrire Int. 2008 Feb;17(93):18. No abstract available.

PMID:
18383636
16.

Hepatitis B vaccine and demyelination (cont'd).

[No authors listed]

Prescrire Int. 1999 Apr;8(40):52.

PMID:
10848063
17.
18.

Hepatitis B vaccine and the risk of CNS inflammatory demyelination in childhood.

Braillon A, Dubois G.

Neurology. 2009 Jun 9;72(23):2053. doi: 10.1212/01.wnl.0000349654.35791.27. No abstract available.

PMID:
19506233
19.

Lumbosacral acute demyelinating polyneuropathy following hepatitis B vaccination.

Créange A, Temam G, Lefaucheur JP.

Autoimmunity. 1999;30(3):143-6.

PMID:
10520897
20.

Gianotti-Crosti syndrome in a child following hepatitis B virus vaccination.

Karakaş M, Durdu M, Tuncer I, Cevlik F.

J Dermatol. 2007 Feb;34(2):117-20. Review.

PMID:
17239149
Items per page

Supplemental Content

Support Center